Tapewire

Nasdaq · USD

SYRE

Spyre Therapeutics, Inc.

Export transactions ↓
Tapewire entity
2649
SEC CIK
0001636282
Parsed reports
239

Last 12 months

Inside the activity.

0 purchase rows · 96 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202502
Jan 202603
Feb 202602
Mar 202604
Apr 202605
May 2026018
Jun 2026011
Jul 202607
Aug 2026011
Sep 2026015
Oct 2026016

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 23, 2023 Filed Feb 24, 2023 23:20 UTC
Alspaugh JonathanChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 640,000 $0.00 Strike: $0.44 $0.00
Disclosure

SEC source: 0001209191-23-012875 · doc4.xml · derivative · entry 1

Alspaugh Jonathan · CIK 0001868112 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 640,000

Underlying: Common Stock · 640,000 shares

Expires 2033-02-22

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 23, 2023, until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
November 29, 2022 Filed Dec 2, 2022 01:47 UTC
Goldberg Jeff MarcDirector · President and CEO
GrantEmployee Stock Option (right to buy) · Derivative 1,884,838 $0.00 Strike: $1.22 $0.00
Disclosure

SEC source: 0001209191-22-059262 · doc4.xml · derivative · entry 1

Goldberg Jeff Marc · CIK 0001703061 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,884,838

Underlying: Common Stock · 1,884,838 shares

Expires 2032-11-28

F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 1/4 of the total award on November 29, 2023, and an additional 1/48 of the award will vest monthly thereafter until the option is 100% vested on November 29, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
November 14, 2022 Filed Jan 27, 2023 23:20 UTC
Neuman Linda LChief Medical Officer
GrantEmployee Stock Option (right to buy) · Derivative 25,000 $0.00 Strike: $1.36 $0.00
Disclosure

SEC source: 0001209191-23-005351 · doc4.xml · derivative · entry 1

Neuman Linda L · CIK 0001951205 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-11-13

F1 · derivative.exercise_date: The stock options will vest as to 1/4th of the total shares on November 14, 2023, and then 1/48th of the shares will vest monthly thereafter, such that the option will become fully vested on November 14, 2026, subject to the Reporting Person's provision of service to the issuer on each vesting date.

Read SEC document
August 25, 2022 Filed Aug 25, 2022 23:37 UTC
Souza MarcioDirector
PurchaseCommon Stock 90,000 $0.56 $50,472.00
Disclosure

SEC source: 0001209191-22-047653 · doc4.xml · nonDerivative · entry 1

Souza Marcio · CIK 0001707657 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,000

Read SEC document
August 23, 2022 Filed Aug 25, 2022 23:39 UTC
Kastenmayer James PaulInterim CEO & General Counsel
GrantEmployee Stock Option (right to buy) · Derivative 130,000 $0.00 Strike: $0.68 $0.00
Disclosure

SEC source: 0001209191-22-047656 · doc4.xml · derivative · entry 1

Kastenmayer James Paul · CIK 0001798800 · Interim CEO & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,000

Underlying: Common Stock · 130,000 shares

Expires 2032-08-22

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 48 equal monthly installments beginning on September 23, 2022 until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors, the stock option will vest as to 80% of the award by January 1, 2023, and 1/48 of the stock option will vest and become exercisable monthly thereafter until such time as the option is 100% vested.

Read SEC document
August 23, 2022 Filed Aug 25, 2022 23:35 UTC
Hanley Jr. Michael ConickChief Business Officer
GrantEmployee Stock Option (right to buy) · Derivative 130,000 $0.00 Strike: $0.68 $0.00
Disclosure

SEC source: 0001209191-22-047649 · doc4.xml · derivative · entry 1

Hanley Jr. Michael Conick · CIK 0001791413 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,000

Underlying: Common Stock · 130,000 shares

Expires 2032-08-22

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 48 equal monthly installments beginning on September 23, 2022 until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors, the stock option will vest as to 80% of the award by January 1, 2023, and 1/48 of the stock option will vest and become exercisable monthly thereafter until such time as the option is 100% vested.

Read SEC document
August 23, 2022 Filed Aug 25, 2022 23:36 UTC
Sloan LeslieChief Operating Officer
GrantEmployee Stock Option (right to buy) · Derivative 130,000 $0.00 Strike: $0.68 $0.00
Disclosure

SEC source: 0001209191-22-047651 · doc4.xml · derivative · entry 1

Sloan Leslie · CIK 0001719455 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,000

Underlying: Common Stock · 130,000 shares

Expires 2032-08-22

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 48 equal monthly installments beginning on September 23, 2022 until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors, the stock option will vest as to 80% of the award by January 1, 2023, and 1/48 of the stock option will vest and become exercisable monthly thereafter until such time as the option is 100% vested.

Read SEC document
August 23, 2022 Filed Aug 25, 2022 23:34 UTC
Alspaugh JonathanChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 130,000 $0.00 Strike: $0.68 $0.00
Disclosure

SEC source: 0001209191-22-047648 · doc4.xml · derivative · entry 1

Alspaugh Jonathan · CIK 0001868112 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,000

Underlying: Common Stock · 130,000 shares

Expires 2032-08-22

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 48 equal monthly installments beginning on September 23, 2022 until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors, the stock option will vest as to 80% of the award by January 1, 2023, and 1/48 of the stock option will vest and become exercisable monthly thereafter until such time as the option is 100% vested.

Read SEC document
June 08, 2022 Filed Jun 10, 2022 22:24 UTC
Hanley Jr. Michael ConickChief Commercial Officer
PurchaseCommon Stock 28,200 $0.71 $20,022.00
Disclosure

SEC source: 0001209191-22-036085 · doc4.xml · nonDerivative · entry 1

Hanley Jr. Michael Conick · CIK 0001791413 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,200

F1 · balance_after: Includes 8,000 shares of common stock acquired by the Reporting Person pursuant to the Issuer's employee stock purchase plan.

Read SEC document
June 07, 2022 Filed Jun 10, 2022 01:21 UTC
Souza MarcioDirector
GrantDirector Stock Option (right to buy) · Derivative 43,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001209191-22-035689 · doc4.xml · derivative · entry 1

Souza Marcio · CIK 0001707657 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,000

Underlying: Common Stock · 43,000 shares

Expires 2032-06-06

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 7, 2022, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date.

Read SEC document
June 07, 2022 Filed Jun 9, 2022 21:22 UTC GrantDirector Stock Option (right to buy) · Derivative 43,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001209191-22-035690 · doc4.xml · derivative · entry 1

Shanafelt Armen · CIK 0001656151 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,000

Underlying: Common Stock · 43,000 shares

Expires 2032-06-06

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 7, 2022, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date.

Read SEC document
June 07, 2022 Filed Jun 10, 2022 01:17 UTC GrantDirector Stock Option (right to buy) · Derivative 43,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001209191-22-035686 · doc4.xml · derivative · entry 1

Magovcevic-Liebisch Ivana · CIK 0001279281 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,000

Underlying: Common Stock · 43,000 shares

Expires 2032-06-06

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 7, 2022, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date.

Read SEC document
June 07, 2022 Filed Jun 9, 2022 21:15 UTC GrantDirector Stock Option (right to buy) · Derivative 43,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001209191-22-035685 · doc4.xml · derivative · entry 1

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,000

Underlying: Common Stock · 43,000 shares

Expires 2032-06-06

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 7, 2022, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date.

Read SEC document
June 07, 2022 Filed Jun 10, 2022 01:18 UTC GrantDirector Stock Option (right to buy) · Derivative 43,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001209191-22-035687 · doc4.xml · derivative · entry 1

Mahatme Sandesh · CIK 0001511034 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,000

Underlying: Common Stock · 43,000 shares

Expires 2032-06-06

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 7, 2022, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date.

Read SEC document
June 07, 2022 Filed Jun 10, 2022 01:13 UTC GrantDirector Stock Option (right to buy) · Derivative 43,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001209191-22-035684 · doc4.xml · derivative · entry 1

Cox Russell J. · CIK 0001512984 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,000

Underlying: Common Stock · 43,000 shares

Expires 2032-06-06

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 7, 2022, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date.

Read SEC document
June 07, 2022 Filed Jun 10, 2022 01:19 UTC GrantDirector Stock Option (right to buy) · Derivative 43,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001209191-22-035688 · doc4.xml · derivative · entry 1

Smith Hunter C · CIK 0001636385 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,000

Underlying: Common Stock · 43,000 shares

Expires 2032-06-06

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 7, 2022, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date.

Read SEC document
June 07, 2022 Filed Jun 10, 2022 10:04 UTC GrantDirector Stock Option (right to buy) · Derivative 43,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001209191-22-035691 · doc4.xml · derivative · entry 1

Lawton Alison Frances · CIK 0001542650 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,000

Underlying: Common Stock · 43,000 shares

Expires 2032-06-06

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 7, 2022, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date.

Read SEC document
March 16, 2022 Filed Mar 18, 2022 06:46 UTC
Quinn Anthony G.Director · President & CEO
PurchaseCommon Stock 80,079 $2.34 $187,705.18
Disclosure

SEC source: 0001209191-22-019929 · doc4.xml · nonDerivative · entry 1

Quinn Anthony G. · CIK 0001532219 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 550,540

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.92 to $2.65 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

Read SEC document
March 15, 2022 Filed Mar 15, 2022 18:32 UTC
Quinn Anthony G.Director · President & CEO
PurchaseCommon Stock 42,417 $1.86 $78,942.28
Disclosure

SEC source: 0001209191-22-018942 · doc4.xml · nonDerivative · entry 3

Quinn Anthony G. · CIK 0001532219 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 473,461

F3 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.89 to $2.00 per share, inclusive.

Read SEC document
March 14, 2022 Filed Mar 15, 2022 18:32 UTC
Quinn Anthony G.Director · President & CEO
PurchaseCommon Stock 67,472 $1.93 $130,220.96
Disclosure

SEC source: 0001209191-22-018942 · doc4.xml · nonDerivative · entry 2

Quinn Anthony G. · CIK 0001532219 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 431,044

F2 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.80 to $1.93 per share, inclusive.

Read SEC document
March 11, 2022 Filed Mar 15, 2022 18:32 UTC
Quinn Anthony G.Director · President & CEO
PurchaseCommon Stock 34,777 $2.06 $71,779.73
Disclosure

SEC source: 0001209191-22-018942 · doc4.xml · nonDerivative · entry 1

Quinn Anthony G. · CIK 0001532219 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 363,572

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.995 to $2.10 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

Read SEC document
March 11, 2022 Filed Mar 15, 2022 22:30 UTC
Alspaugh JonathanChief Financial Officer
PurchaseCommon Stock 75,000 $2.08 $156,000.00
Disclosure

SEC source: 0001209191-22-018941 · doc4.xml · nonDerivative · entry 1

Alspaugh Jonathan · CIK 0001868112 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,372

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.05 to $2.10 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

Read SEC document
February 17, 2022 Filed Feb 22, 2022 16:57 UTC
Quinn Anthony G.Director · President & CEO
GrantEmployee Stock Option (right to buy) · Derivative 350,000 $0.00 Strike: $3.17 $0.00
Disclosure

SEC source: 0001209191-22-011724 · doc4.xml · derivative · entry 1

Quinn Anthony G. · CIK 0001532219 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 350,000

Underlying: Common Stock · 350,000 shares

Expires 2032-02-16

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 17, 2022, until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
February 17, 2022 Filed Feb 22, 2022 21:54 UTC
Sloan LeslieChief Operating Officer
GrantEmployee Stock Option (right to buy) · Derivative 180,000 $0.00 Strike: $3.17 $0.00
Disclosure

SEC source: 0001209191-22-011715 · doc4.xml · derivative · entry 1

Sloan Leslie · CIK 0001719455 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,000

Underlying: Common Stock · 180,000 shares

Expires 2032-02-16

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 17, 2022, until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
February 17, 2022 Filed Feb 22, 2022 21:55 UTC
Weber StevenVP, Controller&Princ Acctg Off
GrantEmployee Stock Option (right to buy) · Derivative 30,000 $0.00 Strike: $3.17 $0.00
Disclosure

SEC source: 0001209191-22-011718 · doc4.xml · derivative · entry 1

Weber Steven · CIK 0001844594 · VP, Controller&Princ Acctg Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2032-02-16

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 17, 2022, until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
February 17, 2022 Filed Feb 22, 2022 21:50 UTC
Alspaugh JonathanChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 170,000 $0.00 Strike: $3.17 $0.00
Disclosure

SEC source: 0001209191-22-011704 · doc4.xml · derivative · entry 1

Alspaugh Jonathan · CIK 0001868112 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,000

Underlying: Common Stock · 170,000 shares

Expires 2032-02-16

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 17, 2022, until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
February 17, 2022 Filed Feb 22, 2022 21:51 UTC
Hanley Jr. Michael ConickChief Commercial Officer
GrantEmployee Stock Option (right to buy) · Derivative 160,000 $0.00 Strike: $3.17 $0.00
Disclosure

SEC source: 0001209191-22-011708 · doc4.xml · derivative · entry 1

Hanley Jr. Michael Conick · CIK 0001791413 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Common Stock · 160,000 shares

Expires 2032-02-16

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 17, 2022, until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
December 13, 2021 Filed Dec 13, 2021 20:41 UTC PurchaseCommon Stock 14,685 $3.65 $53,600.25
Disclosure

SEC source: 0001209191-21-069351 · doc4.xml · nonDerivative · entry 3

Shanafelt Armen · CIK 0001656151 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Read SEC document
December 10, 2021 Filed Dec 13, 2021 20:41 UTC PurchaseCommon Stock 13,516 $3.65 $49,333.40
Disclosure

SEC source: 0001209191-21-069351 · doc4.xml · nonDerivative · entry 2

Shanafelt Armen · CIK 0001656151 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,315

Read SEC document
December 10, 2021 Filed Dec 13, 2021 20:39 UTC
Quinn Anthony G.Director · President & CEO
PurchaseCommon Stock 10,526 $3.75 $39,472.50
Disclosure

SEC source: 0001209191-21-069350 · doc4.xml · nonDerivative · entry 2

Quinn Anthony G. · CIK 0001532219 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328,795

F3 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.62 to $3.80 per share, inclusive.

F2 · balance_after: Includes 963 shares of common stock acquired by the Reporting Person on August 15, 2020, 917 shares of common stock acquired by the Reporting Person on February 17, 2021, and 1,107 shares of common stock acquired by the Reporting Person on August 15, 2021 pursuant to the Issuer's employee stock purchase plan.

Read SEC document
December 09, 2021 Filed Dec 13, 2021 20:41 UTC PurchaseCommon Stock 121,799 $3.67 $446,758.73
Disclosure

SEC source: 0001209191-21-069351 · doc4.xml · nonDerivative · entry 1

Shanafelt Armen · CIK 0001656151 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,799

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.53 to $3.75 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

Read SEC document
December 09, 2021 Filed Dec 13, 2021 20:39 UTC
Quinn Anthony G.Director · President & CEO
PurchaseCommon Stock 43,108 $3.70 $159,499.60
Disclosure

SEC source: 0001209191-21-069350 · doc4.xml · nonDerivative · entry 1

Quinn Anthony G. · CIK 0001532219 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 318,269

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.55 to $3.85 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (3) to this Form 4.

F2 · balance_after: Includes 963 shares of common stock acquired by the Reporting Person on August 15, 2020, 917 shares of common stock acquired by the Reporting Person on February 17, 2021, and 1,107 shares of common stock acquired by the Reporting Person on August 15, 2021 pursuant to the Issuer's employee stock purchase plan.

Read SEC document
December 09, 2021 Filed Dec 14, 2021 01:37 UTC
Alspaugh JonathanChief Financial Officer
PurchaseCommon Stock 50,000 $3.72 $186,000.00
Disclosure

SEC source: 0001209191-21-069349 · doc4.xml · nonDerivative · entry 1

Alspaugh Jonathan · CIK 0001868112 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,372

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.64 to $3.94 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

Read SEC document
November 12, 2021 Filed Nov 16, 2021 21:34 UTC GrantDirector Stock Option (right to buy) · Derivative 60,000 $0.00 Strike: $7.04 $0.00
Disclosure

SEC source: 0001209191-21-064771 · doc4.xml · derivative · entry 1

Smith Hunter C · CIK 0001636385 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2031-11-11

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 36 equal monthly installments beginning on December 12, 2021 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

Read SEC document
October 20, 2021 Filed Feb 14, 2022 17:19 UTC
Quinn Anthony G.Director · President & CEO
GiftCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-009407 · doc5.xml · nonDerivative · entry 8

Quinn Anthony G. · CIK 0001532219 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 208,845

F2 · ownership.nature: These securities are held by the Quinn Family Irrevocable Trust of 2021, of which the Reporting Person's spouse is trustee.

Read SEC document
October 20, 2021 Filed Feb 14, 2022 17:19 UTC
Quinn Anthony G.Director · President & CEO
GiftCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-009407 · doc5.xml · nonDerivative · entry 7

Quinn Anthony G. · CIK 0001532219 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328,795

Read SEC document
October 18, 2021 Filed Feb 14, 2022 17:19 UTC
Quinn Anthony G.Director · President & CEO
GiftCommon Stock 23,809 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-009407 · doc5.xml · nonDerivative · entry 6

Quinn Anthony G. · CIK 0001532219 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 208,845

F2 · ownership.nature: These securities are held by the Quinn Family Irrevocable Trust of 2021, of which the Reporting Person's spouse is trustee.

Read SEC document
October 18, 2021 Filed Feb 14, 2022 17:19 UTC
Quinn Anthony G.Director · President & CEO
GiftCommon Stock 23,809 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-009407 · doc5.xml · nonDerivative · entry 5

Quinn Anthony G. · CIK 0001532219 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328,795

Read SEC document
October 14, 2021 Filed Feb 14, 2022 17:19 UTC
Quinn Anthony G.Director · President & CEO
GiftCommon Stock 175,036 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-009407 · doc5.xml · nonDerivative · entry 4

Quinn Anthony G. · CIK 0001532219 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 208,845

F2 · ownership.nature: These securities are held by the Quinn Family Irrevocable Trust of 2021, of which the Reporting Person's spouse is trustee.

Read SEC document
October 14, 2021 Filed Feb 14, 2022 17:19 UTC
Quinn Anthony G.Director · President & CEO
GiftCommon Stock 175,036 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-009407 · doc5.xml · nonDerivative · entry 3

Quinn Anthony G. · CIK 0001532219 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328,795

Read SEC document
August 18, 2021 Filed Aug 18, 2021 21:21 UTC
Alspaugh JonathanChief Financial Officer
PurchaseCommon Stock 7,200 $6.72 $48,399.84
Disclosure

SEC source: 0001209191-21-052272 · doc4.xml · nonDerivative · entry 3

Alspaugh Jonathan · CIK 0001868112 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,372

F3 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.69 to $6.77 per share, inclusive.

Read SEC document
August 17, 2021 Filed Aug 18, 2021 21:21 UTC
Alspaugh JonathanChief Financial Officer
PurchaseCommon Stock 23,392 $6.50 $151,984.84
Disclosure

SEC source: 0001209191-21-052272 · doc4.xml · nonDerivative · entry 2

Alspaugh Jonathan · CIK 0001868112 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,172

F2 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.40 to $6.6 per share, inclusive.

Read SEC document
August 16, 2021 Filed Aug 18, 2021 21:21 UTC
Alspaugh JonathanChief Financial Officer
PurchaseCommon Stock 9,780 $6.37 $62,275.13
Disclosure

SEC source: 0001209191-21-052272 · doc4.xml · nonDerivative · entry 1

Alspaugh Jonathan · CIK 0001868112 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,780

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.13 to $6.40 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.

Read SEC document
July 06, 2021 Filed Jul 8, 2021 21:12 UTC
Alspaugh JonathanChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 160,000 $0.00 Strike: $7.03 $0.00
Disclosure

SEC source: 0001209191-21-046007 · doc4.xml · derivative · entry 1

Alspaugh Jonathan · CIK 0001868112 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Common Stock · 160,000 shares

Expires 2031-07-05

F1 · derivative.exercise_date: The options will vest as to 1/4th of the total shares on July 6, 2022, and then 1/48th of the shares will vest monthly thereafter, such that the option is fully vested on July 6, 2025, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
June 18, 2021 Filed Jun 22, 2021 20:07 UTC
Souza MarcioDirector
GrantDirector Stock Option (right to buy) · Derivative 60,000 $0.00 Strike: $6.44 $0.00
Disclosure

SEC source: 0001209191-21-042377 · doc4.xml · derivative · entry 1

Souza Marcio · CIK 0001707657 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2031-06-17

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 36 equal monthly installments beginning on July 18, 2021 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

Read SEC document
June 08, 2021 Filed Jun 9, 2021 17:27 UTC GrantDirector Stock Option (right to buy) · Derivative 40,000 $0.00 Strike: $6.80 $0.00
Disclosure

SEC source: 0001209191-21-039233 · doc4.xml · derivative · entry 1

Shanafelt Armen · CIK 0001656151 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2031-06-07

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 8, 2021, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date.

Read SEC document
June 08, 2021 Filed Jun 9, 2021 21:25 UTC GrantDirector Stock Option (right to buy) · Derivative 40,000 $0.00 Strike: $6.80 $0.00
Disclosure

SEC source: 0001209191-21-039229 · doc4.xml · derivative · entry 1

Magovcevic-Liebisch Ivana · CIK 0001279281 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2031-06-07

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 8, 2021, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date.

Read SEC document
June 08, 2021 Filed Jun 9, 2021 17:23 UTC GrantDirector Stock Option (right to buy) · Derivative 40,000 $0.00 Strike: $6.80 $0.00
Disclosure

SEC source: 0001209191-21-039226 · doc4.xml · derivative · entry 1

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2031-06-07

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 8, 2021, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date.

Read SEC document
June 08, 2021 Filed Jun 9, 2021 21:26 UTC GrantDirector Stock Option (right to buy) · Derivative 40,000 $0.00 Strike: $6.80 $0.00
Disclosure

SEC source: 0001209191-21-039231 · doc4.xml · derivative · entry 1

Mahatme Sandesh · CIK 0001511034 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2031-06-07

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 8, 2021, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date.

Read SEC document
June 08, 2021 Filed Jun 9, 2021 21:23 UTC GrantDirector Stock Option (right to buy) · Derivative 40,000 $0.00 Strike: $6.80 $0.00
Disclosure

SEC source: 0001209191-21-039224 · doc4.xml · derivative · entry 1

Cox Russell J. · CIK 0001512984 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2031-06-07

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 8, 2021, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.